Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of triplex CMV vaccine in CAR T cell therapy

Use of triplex CMV vaccine in CAR T cell therapy

US Patent 12478672 · Granted Nov 25, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CAR for treatment of HIV infection2025
CAR for treatment of HIV infection2025
CS1 targeted chimeric antigen receptor-modified T cells2025
CS1 targeted chimeric antigen receptor-modified T cells2025
Administration of engineered T cells for treatment of cancers in the central ner2025
Oncolytic virus expressing a car T cell target and uses thereof2025
Genetically stable recombinant modified vaccinia Ankara (RMVA) vaccines and meth2025
TAG72 targeted chimeric antigen receptor modified T cells for treatment of TAG722025
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2024
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2024
MVA vaccine for delivery of a UL128 complex and preventing CMV infection2024
T cells for expression of chimeric antigen receptors and other receptors2024